Maoxiong Fu

ORCID: 0000-0003-2950-0909
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Diabetic Foot Ulcer Assessment and Management
  • Wound Healing and Treatments
  • Diabetes Management and Research
  • Metabolism, Diabetes, and Cancer
  • Pancreatic function and diabetes
  • Adipokines, Inflammation, and Metabolic Diseases
  • Blood properties and coagulation
  • Angiogenesis and VEGF in Cancer
  • Gastroesophageal reflux and treatments
  • Apelin-related biomedical research
  • Adipose Tissue and Metabolism
  • Bariatric Surgery and Outcomes
  • Laser Applications in Dentistry and Medicine

Hainan Medical University
2018-2024

Background Adipokines have been implicated in the pathogenesis of type 2 diabetes mellitus (T2DM) and related complications due to their roles metabolic regulation inflammation. However, relationship between these adipokines diabetic peripheral neuropathy (DPN) remains unclear. Methods A case-control study was performed with 198 patients DPN 205 T2DM without from Endocrinology Department at Second Affiliated Hospital Hainan Medical University. Circulating adiponectin leptin levels were...

10.3389/fendo.2024.1505082 article EN cc-by Frontiers in Endocrinology 2024-12-13

Objective. To investigate the effect of infrared combined with methylcobalamin on vibratory sensory threshold and lower limb nerve conduction velocity patients diabetic foot. Methods. One hundred six foot in our hospital from February 2018 to December 2020 were enrolled divided into study control groups. The group given methylcobalamin, research treated light basis group. therapeutic effect, vibration threshold, velocity, related biochemical index levels before after treatment two groups...

10.1155/2022/8287192 article EN cc-by Disease Markers 2022-08-28

Abstract Improvement of glucose and insulin sensitivity remains an unmet medical need in diabetes management, which the underlying cause type 2 diabetes(T2D) was not well addressed by current treatment. We report findings a randomized, double-blind, placebo-controlled, phase 3 clinical trial (NCT03173391) to evaluate efficacy safety dorzagliatin, dual-acting glucokinase (GK) allosteric modulator, enhances GK activity T2D patients dependent manner, has demonstrated its effects blood control...

10.21203/rs.3.rs-733611/v1 preprint EN cc-by Research Square (Research Square) 2021-07-22
Coming Soon ...